Cytotoxicity assessment of exfoliated MoS 2 using primary human mast cells and the progenitor cell-derived mast cell line LAD2 - Archive ouverte du site Alsace Accéder directement au contenu
Article Dans Une Revue Nanoscale Advances Année : 2024

Cytotoxicity assessment of exfoliated MoS 2 using primary human mast cells and the progenitor cell-derived mast cell line LAD2

Résumé

Molybdenum disulfide is an emerging 2D material with several potential applications in medicine. Therefore, it is crucial to ascertain its biocompatibility. Mast cells are immune cells that are found in many organs and tissues in contact with the extracellular environment, and can be cultured from progenitor cells present in the bone marrow. Given the long period required for differentiation and proliferation of primary mast cells, human mast cell lines have emerged as a tractable model for biological and toxicological studies. Here, we compare two types of industrial MoS2 using CD34+-derived primary human mast cells and the LAD2 cell line. Minimal effects were observed on early-stage activation endpoints such as β-hexosaminidase release and expression of surface markers of mast cell activation. Transmission electron microscopy revealed limited uptake of the tested materials. Overall, MoS2 was found to be biocompatible, and the LAD2 cell line was validated as a useful in vitro model of mast cells
Fichier principal
Vignette du fichier
Lin et al. Nanoscale Adv. 2024 N347.pdf (1017.75 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04659891 , version 1 (23-07-2024)

Identifiants

Citer

Hazel Lin, Antonio Esau del Rio Castillo, Viviana Jehová González, Francesco Bonaccorso, Ester Vázquez, et al.. Cytotoxicity assessment of exfoliated MoS 2 using primary human mast cells and the progenitor cell-derived mast cell line LAD2. Nanoscale Advances, 2024, 6 (9), pp.2419-2430. ⟨10.1039/d3na00863k⟩. ⟨hal-04659891⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More